Archives
-
Atorvastatin Workflows for Vascular and Ferroptosis Studies
2026-09-03
Atorvastatin is more than a cholesterol-biosynthesis probe: it connects HMG-CoA reductase inhibition with vascular phenotypes, ER-stress biology, and emerging ferroptosis research. This workflow-centered guide covers dosing, assay selection, formulation, controls, and troubleshooting for reproducible bench studies.
-
N1-Methylpseudo-UTP for RNA Synthesis
2026-09-03
N1-Methyl-Pseudouridine-5'-Triphosphate is a modified uridine triphosphate for in vitro transcription of research and therapeutic RNA. N1-Methylpseudo-UTP supports reduced innate immune recognition and faithful translation, but it does not replace RNA capping, purification, delivery, or formulation controls.
-
EZ Cap™ EPO mRNA (ψUTP) Guide
2026-09-02
Learn how SKU R1020 can improve consistency in mammalian viability, proliferation, cytotoxicity, and protein-expression workflows. This scenario-based guide covers Cap 1 chemistry, pseudouridine, handling, assay controls, and practical vendor selection.
-
In Vitro Drug Responses: Growth Inhibition and Cell Death
2026-09-02
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that these commonly conflated measurements capture different components of anticancer drug response. The work supports time-resolved, dual-endpoint assay designs that separately evaluate proliferative arrest and cell killing before drawing conclusions about drug activity.
-
ATRX Loss Sensitizes High-Grade Glioma to RTK Inhibitors
2026-09-01
The 2022 Cancers study identified ATRX deficiency as a genotype-associated vulnerability to multi-targeted receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma cells. Its results support incorporating ATRX status into targeted-therapy studies and evaluating RTK inhibitor–temozolomide combinations in molecularly stratified models.
-
NADH as a Translational Redox Decision Tool
2026-09-01
NADH is more than an energy-metabolism reagent: it is a context-dependent signal that links glycolysis, mitochondrial respiration, oxidative stress, and disease phenotypes. This thought-leadership article interprets findings from a 2024 liver-injury study and translates them into practical guidance for mitochondrial, renal, neurodegenerative, and cancer researchers while clarifying the evidence boundaries around NADH-based interventions.
-
hCG, H3K27 Methylation, and CXCL10 in Decidua
2026-08-31
The reference study shows that human chorionic gonadotropin suppresses CXCL10 in human decidual stromal cells by promoting EZH2-associated H3K27me3 at the CXCL10 promoter. This provides a mechanistic link between placental hormone signaling, chromatin modification, and CD8-cell recruitment at the maternal–fetal interface.
-
Optimized hiPSC Platelet Differentiation: Study Review
2026-08-31
Yue and colleagues developed an optimized differentiation scheme for producing megakaryocytes and functional platelets from human induced pluripotent stem cells. By increasing embryoid body input, using human platelet lysate, replacing selected cytokines with small molecules, and promoting megakaryocyte maturation, the protocol shortened production to 19 days, increased platelet output, and reduced reported costs.
-
GSK 2837808A: LDHA Inhibition Workflow
2026-08-30
Use GSK 2837808A to connect LDHA activity with lactate release, glucose consumption, and tumor-cell signaling in controlled cell-based experiments. This workflow also shows how to test the NAT1–ENO1–lactate–PD-L1 model without overstating evidence from a compound that was not evaluated in the reference study.
-
EdU Imaging Kits (Cy5) for ccRCC Proliferation
2026-08-29
EdU Imaging Kits (Cy5) convert S-phase DNA synthesis into a sensitive, morphology-preserving readout for microscopy and flow cytometry. Applied to the NME3–mitochondrial dynamics study, the assay helps distinguish reduced proliferation after gene knockdown or TKI exposure from broader changes in cell health.
-
Lipid Peroxidation (MDA) Assay Kit in SA-AKI
2026-08-28
The Lipid Peroxidation (MDA) Assay Kit provides dual-mode malondialdehyde quantification for studying ferroptosis and oxidative injury in sepsis-associated acute kidney injury. This guide translates recent LCN2–AMPK/SIRT3/FOXO3a findings into practical assay design, controls, and interpretation decisions.
-
BIRB 796 Workflow for p38α MAPK Studies
2026-08-28
BIRB 796, also called Doramapimod, combines subnanomolar p38α engagement with an allosteric mechanism suited to inflammation, cytokine, and apoptosis workflows. This guide translates that profile into practical assay design, phosphatase-aware experiments, and troubleshooting strategies for reproducible research.
-
AP20187 Chemical Inducer of Dimerization Guide
2026-08-27
AP20187 enables time-controlled activation of engineered signaling proteins, making it useful for conditional gene expression, cell therapy, and metabolic assays. This guide connects practical CID workflows with a chronic intermittent hypoxia model to show how programmable activation can strengthen macrophage–nociceptor experiments without overstating the reference study’s findings.
-
Primidone Inhibits TRPM3 in Adenomyosis
2026-08-27
A 2025 study links increased TRP-channel expression with adenomyosis symptoms and tests Primidone as a pharmacological intervention in a tamoxifen-induced mouse model. The work identifies TRPM3 as a plausible analgesic and disease-modifying target while highlighting the need for clinical validation, target-engagement studies, and better dose translation.
-
CTCF, Centromere Function, and Mitotic Fidelity
2026-08-26
The reference study uses rapid, inducible CTCF degradation to show that CTCF maintains centromere mechanics, metaphase plate organization, accurate mitosis, and post-mitotic nuclear shape. Its findings distinguish CTCF loss from primary CENP-E recruitment defects and support a model in which CTCF contributes to centromeric chromatin function, potentially alongside cohesin.